These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 30019100)
1. Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro. Weinreich J; Struller F; Sautkin I; Giuashvili S; Reymond M; Königsrainer A; Schott TC Invest New Drugs; 2019 Jun; 37(3):415-423. PubMed ID: 30019100 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites. Weinreich J; Struller F; Küper M; Hack A; Königsrainer A; Schott TC Anticancer Drugs; 2013 Apr; 24(4):375-83. PubMed ID: 23358120 [TBL] [Abstract][Full Text] [Related]
3. ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof. Schott S; Wallwiener M; Kootz B; Seeger H; Fehm T; Neubauer H Invest New Drugs; 2011 Jun; 29(3):506-13. PubMed ID: 19997962 [TBL] [Abstract][Full Text] [Related]
4. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center. Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545 [TBL] [Abstract][Full Text] [Related]
5. Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC). Schubert J; Khosrawipour V; Chaudhry H; Arafkas M; Knoefel WT; Pigazzi A; Khosrawipour T World J Surg Oncol; 2019 Jun; 17(1):93. PubMed ID: 31159819 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells. Khosrawipour V; Diaz-Carballo D; Acikelli AH; Khosrawipour T; Falkenstein TA; Wu D; Zieren J; Giger-Pabst U World J Surg Oncol; 2017 Feb; 15(1):43. PubMed ID: 28183319 [TBL] [Abstract][Full Text] [Related]
7. Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines. Weinreich J; Schott S; Königsrainer I; Zieker D; Königsrainer A; Schott H Invest New Drugs; 2011 Dec; 29(6):1294-302. PubMed ID: 20596746 [TBL] [Abstract][Full Text] [Related]
8. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950 [TBL] [Abstract][Full Text] [Related]
9. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report. Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218 [TBL] [Abstract][Full Text] [Related]
10. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367 [TBL] [Abstract][Full Text] [Related]
11. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Tempfer CB; Celik I; Solass W; Buerkle B; Pabst UG; Zieren J; Strumberg D; Reymond MA Gynecol Oncol; 2014 Feb; 132(2):307-11. PubMed ID: 24275155 [TBL] [Abstract][Full Text] [Related]
12. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Tempfer CB; Giger-Pabst U; Seebacher V; Petersen M; Dogan A; Rezniczek GA Gynecol Oncol; 2018 Jul; 150(1):23-30. PubMed ID: 29743140 [TBL] [Abstract][Full Text] [Related]
13. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis. Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403 [TBL] [Abstract][Full Text] [Related]
14. PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model. Davigo A; Passot G; Vassal O; Bost M; Tavernier C; Decullier E; Bakrin N; Alyami M; Bonnet JM; Louzier V; Paquet C; Allaouchiche B; Glehen O; Kepenekian V Int J Hyperthermia; 2020; 37(1):144-150. PubMed ID: 32003300 [No Abstract] [Full Text] [Related]
15. First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies. Kockelmann F; Giger-Pabst U; Ouaissi M; Bucur P; Barbey S; VON Ardenne A; Zieren J Anticancer Res; 2024 Jul; 44(7):3043-3050. PubMed ID: 38925817 [TBL] [Abstract][Full Text] [Related]
16. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis. Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612 [TBL] [Abstract][Full Text] [Related]
17. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study. Tavernier C; Passot G; Vassal O; Allaouchiche B; Decullier E; Bakrin N; Alyami M; Davigo A; Bonnet JM; Louzier V; Paquet C; Glehen O; Kepenekian V Surg Endosc; 2020 Jul; 34(7):2939-2946. PubMed ID: 31456025 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis. Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745 [TBL] [Abstract][Full Text] [Related]
20. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology. Dueckelmann AM; Fink D; Harter P; Heinzelmann V; Marth C; Mueller M; Reinthaller A; Tamussino K; Wimberger P; Sehouli J Arch Gynecol Obstet; 2018 Apr; 297(4):837-846. PubMed ID: 29356953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]